Insider · CIK 0001905191
Kerry Xuefeng Chen
Files at RERE (ATRenew Inc.). First filing -, latest -.
Kerry Xuefeng Chen files SEC Form 4 as CEO and director at RERE (ATRenew Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Kerry Xuefeng Chen has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 15 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 25, 2026 | RERE ATRenew Inc. | MOption exercise American depositary shares | +8,423,097 | - | - | 9,134,518 | Mar 26, 2026 |
| Mar 25, 2026 | RERE ATRenew Inc. | MOption exercise Options (Right to Buy)derivative | -407,200 | $0.00 | $0 | 0 | Mar 26, 2026 |
| Mar 25, 2026 | RERE ATRenew Inc. | MOption exercise Options (Right to Buy)derivative | -19,844 | $0.00 | $0 | 0 | Mar 26, 2026 |
| Mar 25, 2026 | RERE ATRenew Inc. | MOption exercise Options (Right to Buy)derivative | -15,314 | $0.00 | $0 | 0 | Mar 26, 2026 |
| Mar 25, 2026 | RERE ATRenew Inc. | MOption exercise Options (Right to Buy)derivative | -75,931 | $0.00 | $0 | 0 | Mar 26, 2026 |
| Mar 25, 2026 | RERE ATRenew Inc. | MOption exercise Options (Right to Buy)derivative | -26,521 | $0.00 | $0 | 0 | Mar 26, 2026 |
| Mar 25, 2026 | RERE ATRenew Inc. | MOption exercise Options (Right to Buy)derivative | -4,793 | $0.00 | $0 | 0 | Mar 26, 2026 |
| Mar 25, 2026 | RERE ATRenew Inc. | MOption exercise Options (Right to Buy)derivative | -70,650 | $0.00 | $0 | 0 | Mar 26, 2026 |
| Mar 25, 2026 | RERE ATRenew Inc. | MOption exercise Options (Right to Buy)derivative | -64,291 | $0.00 | $0 | 0 | Mar 26, 2026 |
| Mar 25, 2026 | RERE ATRenew Inc. | MOption exercise Options (Right to Buy)derivative | -1,725,746 | $0.00 | $0 | 0 | Mar 26, 2026 |
| Mar 25, 2026 | RERE ATRenew Inc. | MOption exercise Restricted share unitsderivative | -2,964,091 | $0.00 | $0 | 0 | Mar 26, 2026 |
| Mar 25, 2026 | RERE ATRenew Inc. | MOption exercise Options (Right to Buy)derivative | -179,030 | $0.00 | $0 | 0 | Mar 26, 2026 |
| Mar 25, 2026 | RERE ATRenew Inc. | MOption exercise Options (Right to Buy)derivative | -1,378 | $0.00 | $0 | 0 | Mar 26, 2026 |
| Mar 25, 2026 | RERE ATRenew Inc. | MOption exercise Options (Right to Buy)derivative | -7,276 | $0.00 | $0 | 0 | Mar 26, 2026 |
| Mar 25, 2026 | RERE ATRenew Inc. | MOption exercise Options (Right to Buy)derivative | -53,333 | $0.00 | $0 | 0 | Mar 26, 2026 |
Questions about Kerry Xuefeng Chen
Answered from the filings on this page, as of the latest one.
Is Kerry Xuefeng Chen buying or selling?
Kerry Xuefeng Chen has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Kerry Xuefeng Chen's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Kerry Xuefeng Chen has 0.
Where does Kerry Xuefeng Chen file Form 4?
Kerry Xuefeng Chen has filed Form 4 at RERE (ATRenew Inc.) as Chief Executive Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.